Sai Parenteral's Limited (NSE:SAIPARENT)
India flag India · Delayed Price · Currency is INR
506.10
+22.95 (4.75%)
At close: Nov 9, 2026

Sai Parenteral's Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23
Revenue
6,7903,8741,6321,538967.96
Revenue Growth
341.58%137.42%6.11%58.85%-
Gross Profit
2,8301,440683.27579.66389.53
Operating Income
490.26267.95317.5222.9138.13
Net Income
249.28142.59144.5490.1743.76
Earnings Per Share
6.074.365.4311.263.07
EPS Growth
-46.06%-19.71%-51.79%266.81%-

Revenue by Segment

Fiscal Year
FY 2026FY 2025
Period EndingMar '26 Mar '25
Branded Generic Formulations
1,4101,304
CDMO Products and Services
2,400326
Total
3,8101,630

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23
Cash & Investments
1,2934,17836.0152.159.82
Total Debt
5,0464,688939.541,188685.47
Net Cash (Debt)
-3,753-509.6-903.53-1,136-675.65
Net Cash Growth
-----
Net Cash Per Share
-91.48-15.59-33.95-141.86-47.41

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23
Operating Cash Flow
-463.97930.51331.49-719.16-127.99
Capital Expenditures
-2,762-2,300-5-27.22-157.41
Free Cash Flow
-3,226-1,369326.49-746.38-285.4
Free Cash Flow Growth
-----

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23
Gross Margin
41.67%37.16%41.88%37.70%40.24%
Operating Margin
7.22%6.92%19.46%14.50%14.27%
Pretax Margin
3.01%3.08%12.20%8.20%7.49%
Profit Margin
3.67%3.68%8.86%5.86%4.52%
FCF Margin
-47.51%-35.34%20.01%-48.54%-29.48%